CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer.
Frederik Marmé, Wiebke Werft, Anne Walter, Sascha Keller, Xiaoli Wang, Axel Benner, Barbara Burwinkel, Peter Sinn, Sarah Hug, Christof Sohn, Niko Bretz, Gerhard Moldenhauer, Christian Rupp, Anne-Kathleen Rupp, Mikhail Y Biakhov, Alberto Bottini, Kay Friedrichs, V A Khailenko, Georgiy M Manikhas, Amparo Ruiz, Pedro Sánchez-Rovira, Armando Santoro, Miguel A Segui, Carlos Villena, Peter Lichter, Glen Kristiansen, Peter Altevogt, Andreas Schneeweiss
Breast cancer research and treatment 2012;132(3):819-31